Noninvasive Monitoring of Changes in Pancreatic Beta-cell Mass by Bioluminescent Imaging in MIP-luc Transgenic Mice

Abstract

We have generated a transgenic mouse model (MIP-luc) that allows real-time imaging of insulin-secreting pancreatic beta cells in living mice. The beta cells of MIP-luc transgenic mice emit a light signal that can be visualized externally by bioluminescent imaging using specialized equipment. In order to determine whether the intensity of the bioluminescent signal accurately reflects changes in beta-cell mass rather than simply transcriptional modulation of the mouse insulin I promoter–luciferase transgene, we examined the correlation between the bioluminescent signal and the beta-cell mass in MIP-luc mice fed a regular or high-fat Western diet. Male MIP-luc mice were fed a standard rodent diet (5% of calories from fat) or a high-fat Western diet (42% from fat) beginning at 4 weeks of age. The bioluminescent signal and beta-cell mass were measured after 6 and 10 weeks on each diet. The body weight, beta-cell mass, and bioluminescent signal increased with age and increased further in mice fed a high-fat diet. There was a statistically significant correlation between beta-cell mass and bioluminescent signal (r²=0.660, p=0.00137). Thus, in vivo bioluminescent imaging can be used to noninvasively monitor changes in beta-cell mass in living MIP-luc mice, and it complements other approaches for monitoring beta-cell mass in states of insulin resistance, obesity, and diabetes.

Key words

diabetes - firefly luciferase - high-fat diet - imaging - insulin - pancreatic beta cell - transgenic mice

References

• 1 Bouwens L, Rooman I. Regulation of pancreatic beta-cell mass.  Physiol Rev. 2005;  85 1255-1270
• 2 Montanya E, Nacher V, Biarnés M, Soler J. Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy.  Diabetes. 2000;  49 1341-1346
• 3 Gottlieb PA, Eisenbarth GS. Diagnosis and treatment of pre-insulin dependent diabetes.  Annu Rev Med. 1998;  49 391-405
• 4 Prentki M, Nolan CJ. Isletbeta cell failure in type 2 diabetes.  J Clin Invest. 2006;  116 1802-1812
• 5 Souza F, Freeby M, Hultman K, Simpson N, Herron A, Witkowsky P, Liu E, Maffei A, Harris PE. Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas.  Curr Med Chem. 2006;  13 2761-2773
• 6 Souza F, Simpson N, Raffo A, Saxena C, Maffei A, Hardy M, Kilbourn M, Goland R, Leibel R, Mann JJ, Heertum RV, Harris PE. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.  J Clin Invest. 2006;  116 1506-1513
• 7 Evgenov N, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo imaging of islet transplantation.  Nat Med. 2006;  12 144-148
• 8 Park SY, Wang X, Chen Z, Chen Z, Powers AC, Magnuson MA, Head WS, Piston DW, Bell GI. Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin 1 promoter-firefly luciferase transgene.  Genesis. 2005;  43 80-86
• 9 Smith SJ, Zhang H, Clermont AO, Powers AC, Kaufman DB, Purchio AF, West DB. In vivo monitoring of pancreatic beta-cells in a transgenic mouse model.  Mol Imaging. 2006;  5 65-75
• 10 Marshall BA, Tordjman K, Host HH, Ensor NJ, Kwon G, Marshall CA, Coleman T, MacDaniel ML, Semenkovich CF. Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency: Islet LPL regulates insulin secretion.  J Biol Chem. 1999;  274 27426-27432
• 11 Johnson JD, Ahmed NT, Luciani DS, Han Z, Tran H, Fujita J Misler S, Edlund H, Polonsky KS. Increased islet apoptosis in Pdx1^+/- mice.  J Clin Invest. 2003;  111 1147-1160

Correspondence